Boulder Hill Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,100
Closed -$378K 139
2023
Q1
$378K Buy
+1,100
New +$371K 0.3% 66

Other funds holding LLY

Boulder Hill Capital Management's LLY Position: Q2 2023 in Review

Boulder Hill Capital Management sold out of Eli Lilly (LLY) in Q2 2023, closing a stake of 1,100 shares — an estimated $378K sold.

Boulder Hill Capital Management first reported a position in LLY in Q1 2023 and held it in 1 quarter. The position peaked at $378K in Q1 2023. 2,814 funds tracked by Wall St. Rank hold LLY as of Q2 2023.

  • Boulder Hill Capital Management reported no remaining Eli Lilly position as of Q2 2023 after selling out during the quarter.
  • Boulder Hill Capital Management sold 1,100 Eli Lilly shares in Q2 2023, an estimated $378K.
  • Boulder Hill Capital Management first reported a position in Eli Lilly in Q1 2023 and held it in 1 quarter.
  • Boulder Hill Capital Management's Eli Lilly position peaked at $378K in Q1 2023.
  • 2,814 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2023.

Based on Boulder Hill Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.